Market cap
$25,026 Mln
Revenue (TTM)
$3,327 Mln
P/E Ratio
47.8
P/B Ratio
8.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$272 Mln
-
ROE
0.2 %
-
ROCE
15 %
-
Industry P/E
51.35
-
EV/EBITDA
29.6
-
Debt to Equity
0.1
-
Book Value
$--
-
EPS
$7.8
-
Face value
--
-
Shares outstanding
70,400,000
10 Years Aggregate
CFO
$4,090.80 Mln
EBITDA
$4,876.40 Mln
Net Profit
$3,152.90 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
West Pharmaceutical Services (WST)
| 22.5 | -3.9 | 11.5 | 27.9 | -1.7 | -2.3 | 15.7 |
|
BSE Sensex*
| -8.4 | 0.6 | 0.9 | -4.1 | 5.5 | 8.1 | 10.6 |
|
S&P 100
| 5.4 | 1.6 | 3.1 | 16.1 | 19.9 | 12.5 | 14.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
West Pharmaceutical Services (WST)
| -16.0 | -6.9 | 49.6 | -49.8 | 65.9 | 89.0 | 54.1 |
|
S&P 100
| 18.7 | 29.0 | 30.8 | -22.1 | 27.6 | 19.3 | 29.5 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
West Pharmaceutical Services (WST)
|
337.0 | 25,025.8 | 3,326.5 | 564.9 | 15.3 | 18.3 | 47.8 | 8.5 |
| 107.3 | 179,511.3 | 46,585.0 | 5,425.0 | 13.3 | 20.8 | 32.6 | 3.4 | |
| 39.8 | 1,774.5 | 569.6 | 10.6 | 3.0 | 2.1 | 166.9 | 3.4 | |
| 0.1 | 2.3 | 16.4 | -2.1 | 7.6 | -- | -- | 29.9 | |
| 199.1 | 135,324.8 | 25,107.0 | 4,004.0 | 15.4 | 7.6 | 31.9 | 2.4 | |
| 83.7 | 47,578.4 | 6,512.3 | 1,004.9 | 13.8 | 19.5 | 49.2 | 4.7 | |
| 361.8 | 120,918.8 | 11,034.4 | 3,138.8 | 33.8 | 17.3 | 38 | 6.5 | |
| 576.4 | 212,686.4 | 46,336.0 | 6,978.0 | 18.6 | 13.1 | 28.9 | 3.8 | |
| 71.0 | 213.8 | 36.1 | 10.5 | 33.9 | 8.7 | 20.5 | 1.7 |
Shareholding Pattern
View DetailsAbout West Pharmaceutical Services (WST)
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments,... Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania. Read more
-
Non-Independent Chair of the Board, President & CEO
Mr. Eric M. Green
-
Senior VP & Chief Commercial Officer
Ms. Cindy Reiss-Clark
-
Headquarters
Exton, PA
-
Website
FAQs for West Pharmaceutical Services (WST)
What is the current share price of West Pharmaceutical Services Inc (WST) Today?
The share price of West Pharmaceutical Services Inc (WST) is $337.00 (NYSE) as of 28-Jul-2026 16:00 EDT. West Pharmaceutical Services Inc (WST) has given a return of -1.71% in the last 3 years.
What is the current PB & PE ratio of West Pharmaceutical Services Inc (WST)?
The P/E ratio of West Pharmaceutical Services Inc (WST) is 47.84 times as on 24-Jul-2026, a 7 discount to its peers’ median range of 51.35 times.
The P/B ratio of West Pharmaceutical Services Inc (WST) is 8.47 times as on 24-Jul-2026, a 148 premium to its peers’ median range of 3.42 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
40.52
|
6.30
|
|
2024
|
49.00
|
9.00
|
|
2023
|
44.50
|
9.17
|
|
2022
|
30.37
|
6.63
|
|
2021
|
54.14
|
15.34
|
What is the 52 Week High and Low of West Pharmaceutical Services Inc (WST)?
The 52-week high and low of West Pharmaceutical Services Inc (WST) are Rs 386.00 and Rs 223.83 as of 29-Jul-2026.
What is the market cap of West Pharmaceutical Services Inc (WST)?
West Pharmaceutical Services Inc (WST) has a market capitalisation of $ 25,026 Mln as on 24-Jul-2026. As per SEBI classification, it is a Large Cap company.
Should I invest in West Pharmaceutical Services Inc (WST)?
Before investing in West Pharmaceutical Services Inc (WST), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.